SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 81 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,074,000 | -63.4% | 902,907 | +0.2% | 0.36% | -59.9% |
| Q4 2021 | $2,936,000 | -27.1% | 900,677 | 0.0% | 0.88% | -31.0% |
| Q3 2021 | $4,026,000 | -7.7% | 900,677 | +12.6% | 1.28% | +18.4% |
| Q2 2021 | $4,360,000 | +195.8% | 800,000 | +379.7% | 1.08% | +271.2% |
| Q3 2020 | $1,474,000 | -49.3% | 166,780 | -38.9% | 0.29% | -65.6% |
| Q2 2020 | $2,909,000 | +4.7% | 272,902 | -41.8% | 0.85% | -8.8% |
| Q1 2020 | $2,778,000 | -10.4% | 468,532 | +4.5% | 0.93% | +26.2% |
| Q4 2019 | $3,099,000 | – | 448,532 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |